You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 11, November 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  STUDIES
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

An Evaluation of Method Reporting and Use in Clinical Trials in Dermatology

Michael Bigby, MD; Robert S. Stern, MD; JudyAnn Bigby, MD

Arch Dermatol. 1985;121(11):1394-1399.


Abstract

• In a survey of 62 clinical trials published in four dermatology journals, recommended methodology was reported 41% of the time. Of the 62 trials, 31 were open drug trials and 27 were controlled trials. Forty-one percent of 13 recommended methodologic items were reported in these articles. The rate of reporting for these items ranged from 3% for power and method of randomization to 76% for loss to follow-up and the use of a control group. There were no differences among journals in reporting methods used. Investigators and editors are encouraged to improve the reporting and use of recommended methodology in clinical trials published in the dermatologic literature.

(Arch Dermatol 1985;121:1394-1399)



Author Affiliations

From the Department of Dermatology and the Charles A. Dana Research Institute, Beth Israel Hospital and Harvard Medical School (Drs M. Bigby and Stern); and the Department of Medicine, Division of General Internal Medicine, Brigham and Women's Hospital and Harvard Medical School (Dr J. Bigby), Boston.


Footnotes

Accepted for publication May 24, 1985.

Reprint requests to Department of Dermatology, Beth Israel Hospital, Boston, MA 02215 (Dr M. Bigby).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

How Well Are Randomized Controlled Trials Reported in the Dermatology Literature?
Adetugbo and Williams
Arch Dermatol 2000;136:381-385.
ABSTRACT | FULL TEXT  

Evidence-Based Medicine in a Nutshell: A Guide to Finding and Using the Best Evidence in Caring for Patients
Bigby
Arch Dermatol 1998;134:1609-1618.
ABSTRACT | FULL TEXT  

The Cochrane Skin Group: Preparing, Maintaining, and Disseminating Systematic Reviews of Clinical Interventions in Dermatology
Williams et al.
Arch Dermatol 1998;134:1620-1626.
ABSTRACT | FULL TEXT  

Quality, Evolution, and Clinical Implications of Randomized, Controlled Trials on the Treatment of Lung Cancer: A Lost Opportunity for Meta-analysis
Nicolucci et al.
JAMA 1989;262:2101-2107.
ABSTRACT  

What Can We Believe?
Brown
Arch Dermatol 1985;121:1391-1393.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.